Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended on 30/06/2026 according to Article 30 of the Listing Rules.
Shareholders' Structure in Arabic (1,603 KB)
Shareholders' Structure in English (1,633 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended on 30/06/2026 according to Article 30 of the Listing Rules.
Shareholders' Structure in Arabic (1,603 KB)
Shareholders' Structure in English (1,633 KB)
Comments